Everything You Need to Know About Moderna's Valuation
Shares of Moderna (NASDAQ: MRNA) have more than tripled so far this year as the biotech has quickly pushed its coronavirus vaccine, mRNA-1273, through the clinical trial process.
Source Fool.com
Shares of Moderna (NASDAQ: MRNA) have more than tripled so far this year as the biotech has quickly pushed its coronavirus vaccine, mRNA-1273, through the clinical trial process.
Source Fool.com